MedTrace Logo

Registry Platform Ovarian and Endometrial Cancer

NCT05129969 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 1975

Last updated 2026-01-28

No results posted yet for this study

Summary

The purpose of the project is to set up a national, prospective, longitudinal, multicenter cohort study, a tumor registry platform, to document uniform data on characteristics, molecular diagnostics, treatment and course of disease, to collect patient-reported outcomes and to establish a decentralized biobank for patients with advanced or metastatic ovarian cancer (OC) or advanced or metastatic endometrial cancer (EC) in Germany.

Conditions

Interventions

OTHER

Physician's choice according to patient's needs.

Routine care as per site standard.

Sponsors & Collaborators

  • iOMEDICO AG

    lead INDUSTRY

Principal Investigators

  • Thomas Decker, Prof.Dr. · Ravensburg

  • Ingolf Juhasz-Böss, Prof.Dr. · Freiburg

  • Elmar Stickeler, Prof.Dr. · Aachen

  • Dirk Watermann, Prof.Dr. · Freiburg

  • Anja Welt, Dr. · Essen

  • Achim Wöckel, Prof.Dr. · Würzburg

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-11-25
Primary Completion
2030-12-31
Completion
2030-12-31

Countries

  • Germany

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05129969 on ClinicalTrials.gov